AKEBIA THERAPEUTICS, INC. Contract with Customer, Performance Obligation Satisfied in Previous Period
AKEBIA THERAPEUTICS, INC. (AKBA) reported Contract with Customer, Performance Obligation Satisfied in Previous Period of $0 for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Notes › Revenue from Contract with Customer
us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod · last filed 2025-11-10
- AKEBIA THERAPEUTICS, INC. contract with customer, performance obligation satisfied in previous period for the quarter ending 2025-09-30 was $0.00.
- AKEBIA THERAPEUTICS, INC. contract with customer, performance obligation satisfied in previous period for the quarter ending 2025-06-30 was $0.00.
- AKEBIA THERAPEUTICS, INC. contract with customer, performance obligation satisfied in previous period for the quarter ending 2025-03-31 was $0.00.
- AKEBIA THERAPEUTICS, INC. contract with customer, performance obligation satisfied in previous period for the quarter ending 2024-12-31 was $0.00.
- AKEBIA THERAPEUTICS, INC. contract with customer, performance obligation satisfied in previous period for fiscal 2024 was $0.00.
- AKEBIA THERAPEUTICS, INC. contract with customer, performance obligation satisfied in previous period for fiscal 2023 was $0.00.
- AKEBIA THERAPEUTICS, INC. contract with customer, performance obligation satisfied in previous period for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- AKEBIA THERAPEUTICS, INC. contract with customer, performance obligation satisfied in previous period for fiscal 2021 was $81.00K, a 99.69% decline from fiscal 2020.
| Period end | Contract with Customer, Performance Obligation Satisfied in Previous Period 3 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 6 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 9 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 4 quarters · filed 2025-11-10 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2025-08-07 | $0.00 derived: sum of 4 quarters · filed 2025-11-10 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-05-08 | $0.00 derived: sum of 3 quarters · filed 2025-11-10 | $0.00 derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $0.00 derived: sum of 3 quarters · filed 2025-11-10 | $0.00 10-K · filed 2025-03-13 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2025-08-07 | $0.00 derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-05-08 | $0.00 derived: sum of 3 quarters · filed 2025-05-08 | $0.00 derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $0.00 derived: sum of 2 quarters · filed 2025-03-13 | $0.00 derived: sum of 3 quarters · filed 2025-03-13 | $0.00 10-K · filed 2025-03-13 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2024-08-08 | $0.00 derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-05-09 | $0.00 derived: sum of 3 quarters · filed 2024-05-09 | $0.00 derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $0.00 derived: sum of 2 quarters · filed 2024-03-14 | $0.00 derived: sum of 3 quarters · filed 2024-03-14 | $0.00 10-K · filed 2024-03-14 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | $81.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-28 | $0.00 10-Q · filed 2023-08-28 | $81.00K derived: sum of 3 quarters · filed 2023-08-28 | $81.00K derived: sum of 4 quarters · filed 2023-08-28 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-08 | $81.00K derived: sum of 2 quarters · filed 2023-08-28 | $81.00K derived: sum of 3 quarters · filed 2023-08-28 | $81.00K derived: sum of 4 quarters · filed 2023-08-28 |
| 2021-12-31 | $81.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | $81.00K derived: sum of 2 quarters · filed 2023-08-28 | $81.00K derived: sum of 3 quarters · filed 2023-08-28 | $81.00K 10-K/A · filed 2023-08-28 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | $4.62M derived: sum of 4 quarters · filed 2023-08-28 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | $4.62M derived: sum of 3 quarters · filed 2023-08-28 | $25.27M derived: sum of 4 quarters · filed 2023-08-28 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | $4.62M derived: sum of 2 quarters · filed 2023-08-28 | $25.27M derived: sum of 3 quarters · filed 2023-08-28 | $28.82M derived: sum of 4 quarters · filed 2023-08-28 |
| 2020-12-31 | $4.62M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | $25.27M derived: sum of 2 quarters · filed 2023-08-28 | $28.82M derived: sum of 3 quarters · filed 2023-08-28 | $25.96M 10-K/A · filed 2023-08-28 |
| 2020-09-30 | $20.65M 10-Q · filed 2021-11-04 | $24.20M derived: sum of 2 quarters · filed 2021-11-04 | $21.35M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $3.56M 10-Q · filed 2021-08-05 | $3.26M 10-Q · filed 2021-08-05 | ||
| 2019-12-31 | $44.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $44.34M derived: sum of 2 quarters · filed 2022-03-01 | $44.34M derived: sum of 3 quarters · filed 2022-03-01 | $45.59M 10-K · filed 2022-03-01 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $1.25M 10-Q · filed 2020-11-05 | $1.10M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-10 | $1.25M 10-Q · filed 2020-08-10 | $1.10M derived: sum of 3 quarters · filed 2021-02-25 | -$17.47M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $1.25M 10-Q · filed 2020-05-05 | $1.10M derived: sum of 2 quarters · filed 2021-02-25 | -$17.47M derived: sum of 3 quarters · filed 2021-02-25 | -$17.28M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$154.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$18.72M derived: sum of 2 quarters · filed 2021-02-25 | -$18.53M derived: sum of 3 quarters · filed 2021-02-25 | $6.66M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$18.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$18.38M derived: sum of 2 quarters · filed 2019-11-12 | $6.81M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $189.00K 10-Q · filed 2019-08-08 | $25.38M 10-Q · filed 2019-08-08 | ||
| 2017-12-31 | $275.00K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |